Hepatitis B Virus X Gene Activates κ B-Like Enhancer Sequences in the Long Terminal Repeat of Human Immunodeficiency Virus 1

The role of the hepatitis B virus (HBV) X gene during virus infection has not been defined. We previously showed that expression of the HBV X gene in the human hepatocellular carcinoma cell line HepG2 trans-activates chloramphenicol acetyltransferase gene expression under control of the human immuno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 1989-07, Vol.86 (13), p.5168-5172
Hauptverfasser: Twu, Jr-Shin, Chu, Keting, Robinson, William S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5172
container_issue 13
container_start_page 5168
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 86
creator Twu, Jr-Shin
Chu, Keting
Robinson, William S.
description The role of the hepatitis B virus (HBV) X gene during virus infection has not been defined. We previously showed that expression of the HBV X gene in the human hepatocellular carcinoma cell line HepG2 trans-activates chloramphenicol acetyltransferase gene expression under control of the human immunodeficiency virus 1 (HIV-1) long terminal repeat and we have now identified a specific sequence in the HIV-1 long terminal repeat that is responsive to the HBV X gene. Plasmid constructs with the chloramphenicol acetyltransferase gene regulated by an isolated and twice-repeated 12-base-pair HIV-1 enhancer sequence homologous to the nucleotide sequence that binds the nuclear transcription factor NF-κ B (the HIV-1 κ B-like sequence) were trans-activated by the HBV X gene in HepG2 cells, indicating that the κ B-like enhancer sequence in the HIV-1 long terminal repeat is responsive to the X gene. When eight copies of the HIV-1 κ B-like sequence were used to regulate β -globin gene expression, transcription of this gene was activated by the HBV X gene in HepG2 cells and no β -globin gene transcription was detected in the absence of the HBV X gene. β -globin gene expression regulated by the activator protein 2 (AP-2) binding sequence was not activated by the HBV X gene. Treatment of HepG2 cells with phorbol ester resulted in modest activation of the HIV-1 κ B-like enhancer sequence suggesting that an NF-κ B-like factor was induced in these cells as it is in T lymphocytes by phorbol ester; however, phorbol ester did not demonstrably enhance the activation of the HIV-1 enhancer observed with the HBV X gene. These experiments indicate that the HIV-1 κ B-like transcriptional enhancer sequence is activated by the HBV X gene and suggest that the HBV X gene might play a role in regulating transcription of a gene under control of a κ B-like enhancer during HBV infection. Since such a sequence has not been found in the HBV genome and HBV gene expression appears not to be regulated by the HBV X gene, a cellular gene that plays a role in HBV replication could be the target of the X gene during HBV infection.
doi_str_mv 10.1073/pnas.86.13.5168
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_79066248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>34068</jstor_id><sourcerecordid>34068</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4368-673f6660fde92fb1313874984183944a2af2b776e03f861dde34166e6a0ec07d3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEKkNhjYQE8gLBKlM7dvyzYNFWpVNpJCQoiJ3lSa47LomT2k5FF7wYD8EzkWjCiG5gZUvnO-f6-mTZc4KXBAt61HsTl5IvCV2WhMsH2YJgRXLOFH6YLTAuRC5ZwR5nT2K8xhirUuKD7KAQDFOmFtmPFfQmueQiOkFfXBgi-orOwQM6rpK7NQki-vUTneRr9w3Qmd8aX0FAn-BmgPEWkfMobQGtO3-FLiG0zpsGfYQeTEKdRauhNR5dtO3guxqsq9xou5snkafZI2uaCM_m8zD7_P7s8nSVrz-cX5wer_OKUS5zLqjlnGNbgyrshlBCpWBKMiKpYswUxhYbIThgaiUndQ2UEc6BGwwVFjU9zN7tcvth00JdgU_BNLoPrjXhTnfG6fuKd1t91d3qQolSqNH_ZvaHblw8Jt26WEHTGA_dELVQmPOCyf-CpBx_XpZT4tEOrEIXYwC7fwzBempWT81qyTWhemp2dLz8e4c9P1c56q9n3cTKNDaMTbm4x7gqOFFTzKsZm_L_qPfmvP0noO3QNAm-p5F8sSOvY-rCHqUMjzG_Aegkzb8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15274859</pqid></control><display><type>article</type><title>Hepatitis B Virus X Gene Activates κ B-Like Enhancer Sequences in the Long Terminal Repeat of Human Immunodeficiency Virus 1</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Twu, Jr-Shin ; Chu, Keting ; Robinson, William S.</creator><creatorcontrib>Twu, Jr-Shin ; Chu, Keting ; Robinson, William S.</creatorcontrib><description>The role of the hepatitis B virus (HBV) X gene during virus infection has not been defined. We previously showed that expression of the HBV X gene in the human hepatocellular carcinoma cell line HepG2 trans-activates chloramphenicol acetyltransferase gene expression under control of the human immunodeficiency virus 1 (HIV-1) long terminal repeat and we have now identified a specific sequence in the HIV-1 long terminal repeat that is responsive to the HBV X gene. Plasmid constructs with the chloramphenicol acetyltransferase gene regulated by an isolated and twice-repeated 12-base-pair HIV-1 enhancer sequence homologous to the nucleotide sequence that binds the nuclear transcription factor NF-κ B (the HIV-1 κ B-like sequence) were trans-activated by the HBV X gene in HepG2 cells, indicating that the κ B-like enhancer sequence in the HIV-1 long terminal repeat is responsive to the X gene. When eight copies of the HIV-1 κ B-like sequence were used to regulate β -globin gene expression, transcription of this gene was activated by the HBV X gene in HepG2 cells and no β -globin gene transcription was detected in the absence of the HBV X gene. β -globin gene expression regulated by the activator protein 2 (AP-2) binding sequence was not activated by the HBV X gene. Treatment of HepG2 cells with phorbol ester resulted in modest activation of the HIV-1 κ B-like enhancer sequence suggesting that an NF-κ B-like factor was induced in these cells as it is in T lymphocytes by phorbol ester; however, phorbol ester did not demonstrably enhance the activation of the HIV-1 enhancer observed with the HBV X gene. These experiments indicate that the HIV-1 κ B-like transcriptional enhancer sequence is activated by the HBV X gene and suggest that the HBV X gene might play a role in regulating transcription of a gene under control of a κ B-like enhancer during HBV infection. Since such a sequence has not been found in the HBV genome and HBV gene expression appears not to be regulated by the HBV X gene, a cellular gene that plays a role in HBV replication could be the target of the X gene during HBV infection.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.86.13.5168</identifier><identifier>PMID: 2740349</identifier><identifier>CODEN: PNASA6</identifier><language>eng</language><publisher>Washington, DC: National Academy of Sciences of the United States of America</publisher><subject>AIDS/HIV ; Base Sequence ; Biological and medical sciences ; Cell Line ; Cell lines ; Enhancer elements ; Enhancer Elements, Genetic ; Fundamental and applied biological sciences. Psychology ; Gene expression ; Gene Expression Regulation ; Genes ; Genes, Viral ; Hep G2 cells ; Hepatitis B virus ; Hepatitis B virus - genetics ; HIV 1 ; HIV-1 - genetics ; human immunodeficiency virus 1 ; Humans ; Molecular and cellular biology ; Molecular genetics ; Molecular Sequence Data ; Plasmids ; Regulatory sequences ; Repetitive Sequences, Nucleic Acid ; T lymphocytes ; Transfection ; Viruses</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1989-07, Vol.86 (13), p.5168-5172</ispartof><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4368-673f6660fde92fb1313874984183944a2af2b776e03f861dde34166e6a0ec07d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/86/13.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/34068$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/34068$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27903,27904,53770,53772,57996,58229</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6926198$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2740349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Twu, Jr-Shin</creatorcontrib><creatorcontrib>Chu, Keting</creatorcontrib><creatorcontrib>Robinson, William S.</creatorcontrib><title>Hepatitis B Virus X Gene Activates κ B-Like Enhancer Sequences in the Long Terminal Repeat of Human Immunodeficiency Virus 1</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The role of the hepatitis B virus (HBV) X gene during virus infection has not been defined. We previously showed that expression of the HBV X gene in the human hepatocellular carcinoma cell line HepG2 trans-activates chloramphenicol acetyltransferase gene expression under control of the human immunodeficiency virus 1 (HIV-1) long terminal repeat and we have now identified a specific sequence in the HIV-1 long terminal repeat that is responsive to the HBV X gene. Plasmid constructs with the chloramphenicol acetyltransferase gene regulated by an isolated and twice-repeated 12-base-pair HIV-1 enhancer sequence homologous to the nucleotide sequence that binds the nuclear transcription factor NF-κ B (the HIV-1 κ B-like sequence) were trans-activated by the HBV X gene in HepG2 cells, indicating that the κ B-like enhancer sequence in the HIV-1 long terminal repeat is responsive to the X gene. When eight copies of the HIV-1 κ B-like sequence were used to regulate β -globin gene expression, transcription of this gene was activated by the HBV X gene in HepG2 cells and no β -globin gene transcription was detected in the absence of the HBV X gene. β -globin gene expression regulated by the activator protein 2 (AP-2) binding sequence was not activated by the HBV X gene. Treatment of HepG2 cells with phorbol ester resulted in modest activation of the HIV-1 κ B-like enhancer sequence suggesting that an NF-κ B-like factor was induced in these cells as it is in T lymphocytes by phorbol ester; however, phorbol ester did not demonstrably enhance the activation of the HIV-1 enhancer observed with the HBV X gene. These experiments indicate that the HIV-1 κ B-like transcriptional enhancer sequence is activated by the HBV X gene and suggest that the HBV X gene might play a role in regulating transcription of a gene under control of a κ B-like enhancer during HBV infection. Since such a sequence has not been found in the HBV genome and HBV gene expression appears not to be regulated by the HBV X gene, a cellular gene that plays a role in HBV replication could be the target of the X gene during HBV infection.</description><subject>AIDS/HIV</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Enhancer elements</subject><subject>Enhancer Elements, Genetic</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>Gene Expression Regulation</subject><subject>Genes</subject><subject>Genes, Viral</subject><subject>Hep G2 cells</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B virus - genetics</subject><subject>HIV 1</subject><subject>HIV-1 - genetics</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Molecular and cellular biology</subject><subject>Molecular genetics</subject><subject>Molecular Sequence Data</subject><subject>Plasmids</subject><subject>Regulatory sequences</subject><subject>Repetitive Sequences, Nucleic Acid</subject><subject>T lymphocytes</subject><subject>Transfection</subject><subject>Viruses</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhSMEKkNhjYQE8gLBKlM7dvyzYNFWpVNpJCQoiJ3lSa47LomT2k5FF7wYD8EzkWjCiG5gZUvnO-f6-mTZc4KXBAt61HsTl5IvCV2WhMsH2YJgRXLOFH6YLTAuRC5ZwR5nT2K8xhirUuKD7KAQDFOmFtmPFfQmueQiOkFfXBgi-orOwQM6rpK7NQki-vUTneRr9w3Qmd8aX0FAn-BmgPEWkfMobQGtO3-FLiG0zpsGfYQeTEKdRauhNR5dtO3guxqsq9xou5snkafZI2uaCM_m8zD7_P7s8nSVrz-cX5wer_OKUS5zLqjlnGNbgyrshlBCpWBKMiKpYswUxhYbIThgaiUndQ2UEc6BGwwVFjU9zN7tcvth00JdgU_BNLoPrjXhTnfG6fuKd1t91d3qQolSqNH_ZvaHblw8Jt26WEHTGA_dELVQmPOCyf-CpBx_XpZT4tEOrEIXYwC7fwzBempWT81qyTWhemp2dLz8e4c9P1c56q9n3cTKNDaMTbm4x7gqOFFTzKsZm_L_qPfmvP0noO3QNAm-p5F8sSOvY-rCHqUMjzG_Aegkzb8</recordid><startdate>19890701</startdate><enddate>19890701</enddate><creator>Twu, Jr-Shin</creator><creator>Chu, Keting</creator><creator>Robinson, William S.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19890701</creationdate><title>Hepatitis B Virus X Gene Activates κ B-Like Enhancer Sequences in the Long Terminal Repeat of Human Immunodeficiency Virus 1</title><author>Twu, Jr-Shin ; Chu, Keting ; Robinson, William S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4368-673f6660fde92fb1313874984183944a2af2b776e03f861dde34166e6a0ec07d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>AIDS/HIV</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Enhancer elements</topic><topic>Enhancer Elements, Genetic</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>Gene Expression Regulation</topic><topic>Genes</topic><topic>Genes, Viral</topic><topic>Hep G2 cells</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B virus - genetics</topic><topic>HIV 1</topic><topic>HIV-1 - genetics</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Molecular and cellular biology</topic><topic>Molecular genetics</topic><topic>Molecular Sequence Data</topic><topic>Plasmids</topic><topic>Regulatory sequences</topic><topic>Repetitive Sequences, Nucleic Acid</topic><topic>T lymphocytes</topic><topic>Transfection</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Twu, Jr-Shin</creatorcontrib><creatorcontrib>Chu, Keting</creatorcontrib><creatorcontrib>Robinson, William S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Twu, Jr-Shin</au><au>Chu, Keting</au><au>Robinson, William S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis B Virus X Gene Activates κ B-Like Enhancer Sequences in the Long Terminal Repeat of Human Immunodeficiency Virus 1</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1989-07-01</date><risdate>1989</risdate><volume>86</volume><issue>13</issue><spage>5168</spage><epage>5172</epage><pages>5168-5172</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><coden>PNASA6</coden><abstract>The role of the hepatitis B virus (HBV) X gene during virus infection has not been defined. We previously showed that expression of the HBV X gene in the human hepatocellular carcinoma cell line HepG2 trans-activates chloramphenicol acetyltransferase gene expression under control of the human immunodeficiency virus 1 (HIV-1) long terminal repeat and we have now identified a specific sequence in the HIV-1 long terminal repeat that is responsive to the HBV X gene. Plasmid constructs with the chloramphenicol acetyltransferase gene regulated by an isolated and twice-repeated 12-base-pair HIV-1 enhancer sequence homologous to the nucleotide sequence that binds the nuclear transcription factor NF-κ B (the HIV-1 κ B-like sequence) were trans-activated by the HBV X gene in HepG2 cells, indicating that the κ B-like enhancer sequence in the HIV-1 long terminal repeat is responsive to the X gene. When eight copies of the HIV-1 κ B-like sequence were used to regulate β -globin gene expression, transcription of this gene was activated by the HBV X gene in HepG2 cells and no β -globin gene transcription was detected in the absence of the HBV X gene. β -globin gene expression regulated by the activator protein 2 (AP-2) binding sequence was not activated by the HBV X gene. Treatment of HepG2 cells with phorbol ester resulted in modest activation of the HIV-1 κ B-like enhancer sequence suggesting that an NF-κ B-like factor was induced in these cells as it is in T lymphocytes by phorbol ester; however, phorbol ester did not demonstrably enhance the activation of the HIV-1 enhancer observed with the HBV X gene. These experiments indicate that the HIV-1 κ B-like transcriptional enhancer sequence is activated by the HBV X gene and suggest that the HBV X gene might play a role in regulating transcription of a gene under control of a κ B-like enhancer during HBV infection. Since such a sequence has not been found in the HBV genome and HBV gene expression appears not to be regulated by the HBV X gene, a cellular gene that plays a role in HBV replication could be the target of the X gene during HBV infection.</abstract><cop>Washington, DC</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>2740349</pmid><doi>10.1073/pnas.86.13.5168</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1989-07, Vol.86 (13), p.5168-5172
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_miscellaneous_79066248
source MEDLINE; Jstor Complete Legacy; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects AIDS/HIV
Base Sequence
Biological and medical sciences
Cell Line
Cell lines
Enhancer elements
Enhancer Elements, Genetic
Fundamental and applied biological sciences. Psychology
Gene expression
Gene Expression Regulation
Genes
Genes, Viral
Hep G2 cells
Hepatitis B virus
Hepatitis B virus - genetics
HIV 1
HIV-1 - genetics
human immunodeficiency virus 1
Humans
Molecular and cellular biology
Molecular genetics
Molecular Sequence Data
Plasmids
Regulatory sequences
Repetitive Sequences, Nucleic Acid
T lymphocytes
Transfection
Viruses
title Hepatitis B Virus X Gene Activates κ B-Like Enhancer Sequences in the Long Terminal Repeat of Human Immunodeficiency Virus 1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A09%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20B%20Virus%20X%20Gene%20Activates%20%CE%BA%20B-Like%20Enhancer%20Sequences%20in%20the%20Long%20Terminal%20Repeat%20of%20Human%20Immunodeficiency%20Virus%201&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Twu,%20Jr-Shin&rft.date=1989-07-01&rft.volume=86&rft.issue=13&rft.spage=5168&rft.epage=5172&rft.pages=5168-5172&rft.issn=0027-8424&rft.eissn=1091-6490&rft.coden=PNASA6&rft_id=info:doi/10.1073/pnas.86.13.5168&rft_dat=%3Cjstor_proqu%3E34068%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15274859&rft_id=info:pmid/2740349&rft_jstor_id=34068&rfr_iscdi=true